Louisiana Man Makes History By Beating Sickle Cell Disease
Share
For the first time in Louisiana history, a young man is proving that what once seemed impossible is now becoming reality.
Twenty-three-year-old Daniel Cressy of Metairie has become the first person in Louisiana and the first in the Gulf Coast region to be declared functionally cured of sickle cell disease through groundbreaking gene-editing therapy. Doctors at Manning Family Children's Hospital announced that after nearly two years of treatment, the disease is no longer active in his body.
<div id="lyvecom_story_event--page"></div>
<script>
(() => {
const scriptElement = document.querySelector('script[data-lyvecom]');
scriptElement.addEventListener('load', () => {
LyveComWidget.mountStoryEventPage({
account: '6a3c89e2acdcd522a15a77e1',
parentElement: '#lyvecom_story_event--page',
lng: 'en',
stories: true,
storyEvent:true,
position: 'left',
positionLeft: '0',
positionBottom: '0'
});
})})()
</script>
Diagnosed as an infant, Cressy spent his life battling the painful inherited blood disorder, which disproportionately affects Black Americans. Sickle cell disease can cause severe pain, organ damage, frequent hospitalizations, and dramatically shorten life expectancy. Louisiana has one of the nation's highest rates of the disease.
The treatment used CRISPR gene-editing technology, which involved harvesting Cressy's own stem cells, sending them to Scotland to be genetically modified, and then reintroducing them into his body after chemotherapy eliminated the diseased cells. Following weeks of recovery, physicians confirmed that his modified cells are now producing healthy red blood cells.
The milestone represents far more than a medical breakthrough for Cressy. Because of his sickle cell diagnosis, the Federal Aviation Administration would not allow him to pursue his lifelong dream of becoming a commercial airline pilot. Now, with the disease behind him, he plans to return to flight training while also launching a nonprofit organization to help others facing medical and economic barriers.
Surrounded by family, doctors, and state leaders, Cressy marked the moment by ringing the hospital's ceremonial bell, a tradition often reserved for cancer patients completing treatment. He described the experience as the beginning of "life two," saying his journey is proof that hope is real and that others living with sickle cell disease should never give up.
Medical experts say this achievement signals a new era in treating sickle cell disease. While gene therapy remains expensive and isn't yet available to every patient, breakthroughs like this are reshaping what is possible for thousands of families who have spent generations living with the disease.